WE sought to determine whether the motor dysfunctions and neuroleptic
sensitivity that can occur in patients with AIDS relates to a deficit
of striatal dopamine innervation similar to that of Parkinson's diseas
e. For this purpose we measured concentrations of dopamine and its maj
or metabolite homovanillic acid (HVA) in caudate nucleus tissue taken
post-mortem from patients with AIDS and from appropriate age-matched c
ontrol subjects. Dopamine and HVA concentrations were both significant
ly reduced in the AIDS group, with 20 of 34 patients exhibiting dopami
ne concentrations below the control range. This finding is consistent
with a loss of nigrostriatal dopaminergic neurones, and may underlie t
he motor dysfunction and neuroleptic sensitivity that can occur in AID
S patients, indicating the potential value of antiparkinsonian therapy
in such patients.